Soluble programmed death-1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B

High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B

(2017) Gi-Ae Kim et al.   GUT

Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm

(2017) Martin Rao et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment

(2017) Xiaoyan Li et al.   Journal of Translational Medicine

Use of Liver Imaging and Biopsy in Clinical Practice

(2017) Elliot B. Tapper et al.   NEW ENGLAND JOURNAL OF MEDICINE

Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis

(2017) Takemichi Fukasawa et al.   Arthritis & Rheumatology

A Practical Model Evaluating Antiviral Cytokines by Natural Killer Cells in Treatment Naïve Patients with Chronic Hepatitis B Virus Infection

(2017) Xiaoyan Li et al.   Scientific Reports

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

(2016) Weiping Zou et al.   Science Translational Medicine

AASLD guidelines for treatment of chronic hepatitis B

(2015) Norah A. Terrault et al.   HEPATOLOGY

Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways

(2015) Cuiping Liu et al.   ARTHRITIS RESEARCH & THERAPY

The PD-1/PD-Ls pathway and autoimmune diseases

(2014) Suya Dai et al.   CELLULAR IMMUNOLOGY

APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS)

(2014) E. Teshale et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis B virus infection

(2014) Christian Trépo et al.   LANCET

PD-1 blockade induces responses by inhibiting adaptive immune resistance

(2014) Paul C. Tumeh et al.   NATURE

Circulating Programmed Death-1 as a Marker for Sustained High Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma

(2014) Hsiang-Yun Cheng et al.   PLoS One

Evaluation of the Aspartate Aminotransferase/Platelet Ratio Index and Enhanced Liver Fibrosis Tests to Detect Significant Fibrosis Due to Chronic Hepatitis C

(2013) John R. Petersen et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines

(2011) Yongjing Chen et al.   CYTOKINE

Soluble PD-1 is Associated with Aberrant Regulation of T Cells Activation in Aplastic Anemia

(2009) Haijing Wu et al.   IMMUNOLOGICAL INVESTIGATIONS

Liver biopsy

(2008) Don C. Rockey et al.   HEPATOLOGY

Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection

(2008) Nattawat Onlamoon et al.   IMMUNOLOGY

Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors

(2007) Giovanna Fattovich et al.   JOURNAL OF HEPATOLOGY